The announcement by President Donald Trump's administration of the results of a probe into pharmaceutical imports and new ...

The Q2 pharma earnings season featured changes in the obesity race as well as insights into drugmakers’ views on tariffs and drug pricing.

OpenSecrets reports the pharma industry led lobbying in Q2 2025, spending $105.4 million, followed by Ballard Partners at $20 ...

Insmed received FDA clearance for the first treatment for a chronic lung disease, opening the way to what could be a ...

A closer look at the top biotechnology and pharmaceutical companies in the 2025 IndustryWeek 500. The pharmaceutical industry ...

By combining the ETHIC bill and a legislative formulation of a withdrawn USPTO rule, Congress has an opportunity to enact ...

After more than a decade of digital transformation, pharmaceutical marketing is on the cusp of achieving what the industry ...

Drugmakers generate most of their sales in the U.S. The Pharmaceutical Research and Manufacturers of America - the industry's ...

Texas AG Ken Paxton sues Eli Lilly for alleged bribery to promote diabetes drugs, claiming violation of state fraud laws and ...

There are also signs pointing to the onset of pharma Industry 4.0, which is characterized by the integration of connectivity, AI and robotics to enable systems that operate with little or no human ...

The pharmaceutical sector, a beacon of innovation, stands tall in Europe's economic landscape. Yet even a robust industry is not immune to financial challenges.